A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Purpose
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.
Condition
- Hepatocellular Cancer
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Male or female patients, age ≥18 years 2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)
Exclusion Criteria
- Inability to provide written informed consent
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Cohort
- Time Perspective
- Prospective
Recruiting Locations
Banner University Medical Center
Phoenix, Arizona 85006
Phoenix, Arizona 85006
University of Arkansas
Little Rock, Arkansas 72205
Little Rock, Arkansas 72205
University of Southern California/Norris Comprehensive Cancer Center
Los Angeles, California 90033
Los Angeles, California 90033
Stanford University
Palo Alto, California 94304
Palo Alto, California 94304
California Liver Research Institute
Pasadena, California 91105
Pasadena, California 91105
University of California-Davis
Sacramento, California 95817
Sacramento, California 95817
University of California
San Francisco, California 94158
San Francisco, California 94158
Georgetown University
Washington, District of Columbia 20007
Washington, District of Columbia 20007
Gastro Florida
Clearwater, Florida 33762
Clearwater, Florida 33762
University of Florida Hepatology Research at CTRB
Gainesville, Florida 32610-0272
Gainesville, Florida 32610-0272
Schiff Center for Liver Diseases/University of Miami
Miami, Florida 33136
Miami, Florida 33136
Piedmont Atlanta Hospital
Atlanta, Georgia 30309
Atlanta, Georgia 30309
Piedmont Cancer Institute
Atlanta, Georgia 30318
Atlanta, Georgia 30318
Northwestern University Division of Gastroenterology and Hepatology
Chicago, Illinois 60611
Chicago, Illinois 60611
University of Chicago
Chicago, Illinois 60637
Chicago, Illinois 60637
University of Iowa Hospitals and Clinics
Iowa City, Iowa 52242
Iowa City, Iowa 52242
Tulane University
New Orleans, Louisiana 70112
New Orleans, Louisiana 70112
Mercy Medical Center, GI Research
Baltimore, Maryland 21202
Baltimore, Maryland 21202
University of Michigan
Ann Arbor, Michigan 48109
Ann Arbor, Michigan 48109
Henry Ford Health System
Detroit, Michigan 48202
Detroit, Michigan 48202
Mayo Clinic
Rochester, Minnesota 55905
Rochester, Minnesota 55905
Southern Therapy and Advanced Research (STAR) LLC
Jackson, Mississippi 39216
Jackson, Mississippi 39216
Saint Louis University
Saint Louis, Missouri 63110
Saint Louis, Missouri 63110
University of Nebraska Medical Center
Omaha, Nebraska 68106
Omaha, Nebraska 68106
NYU Langone Health
New York, New York 10016
New York, New York 10016
Weill Cornell Medical College
New York, New York 10021
New York, New York 10021
Columbia University
New York, New York 10032
New York, New York 10032
Center for Liver Disease and Transplant at CMC
Charlotte, North Carolina 28204
Charlotte, North Carolina 28204
Providence Health & Services Cancer Clinical Trials
Portland, Oregon 97213
Portland, Oregon 97213
University of Pennsylvania
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
Medical University of South Carolina
Charleston, South Carolina 29403
Charleston, South Carolina 29403
Vanderbilt University Medical Center - GI Research Office
Nashville, Tennessee 37212
Nashville, Tennessee 37212
Clinical Research Institute@ Methodist Dallas Medical Center
Dallas, Texas 75203
Dallas, Texas 75203
University of Texas Southwestern Medical Center
Dallas, Texas 75390-8887
Dallas, Texas 75390-8887
Baylor Scott & White All Saints
Fort Worth, Texas 76104
Fort Worth, Texas 76104
University of Virginia
Charlottesville, Virginia 22908
Charlottesville, Virginia 22908
Bon Secours Liver Institute of Virginia
Richmond, Virginia 23226
Richmond, Virginia 23226
Virginia Commonwealth University
Richmond, Virginia 23298
Richmond, Virginia 23298
University of Wisconsin
Madison, Wisconsin 53705-2281
Madison, Wisconsin 53705-2281
More Details
- NCT ID
- NCT02954094
- Status
- Recruiting
- Sponsor
- Target PharmaSolutions, Inc.